1. Induction of humoral and cell-mediated immunity to hepatitis B surface antigen by a novel adjuvant activity of Oka varicella vaccine.
- Author
-
Phumiamorn S, Sato H, Kamiyama T, Kurokawa M, and Shiraki K
- Subjects
- Animals, Guinea Pigs, Hepatitis B virus immunology, Hepatitis B, Chronic immunology, Hepatitis B, Chronic prevention & control, Humans, Hypersensitivity, Delayed, Immunization, Th1 Cells immunology, Adjuvants, Immunologic, Chickenpox Vaccine immunology, Hepatitis B Antibodies blood, Hepatitis B Surface Antigens immunology, Hepatitis B Vaccines immunology, Immunity, Cellular
- Abstract
Oka varicella vaccine induces humoral and cell-mediated immunity to varicella-zoster virus (VZV), even in immunocompromised hosts. This vaccine showed novel adjuvant activity against co-inoculated hepatitis B surface antigen (HBsAg). Either a mixed inoculation of HBsAg with heat-inactivated Oka varicella vaccine at one site or a separate inoculation of HBsAg and live vaccine at different sites induced an antibody response but failed to induce delayed type hypersensitivity (DTH) to HBsAg. In contrast, immunization of HBsAg mixed with live vaccine induced DTH and an enhanced antibody response to HBsAg. The adjuvant activity of Oka varicella vaccine was similar in terms of antibody production to that of alum adjuvant. A T helper cell-dominant immunity to VZV and HBsAg continued for 1 year. Oka varicella vaccine combined with a foreign antigen may serve as a novel polyvalent vaccine for the infectious diseases for which cell-mediated immunity is beneficial.
- Published
- 2003
- Full Text
- View/download PDF